2.4774
price up icon3.13%   0.0774
 
loading
Annexon Inc stock is traded at $2.4774, with a volume of 494.47K. It is up +3.13% in the last 24 hours and up +21.32% over the past month. Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$2.40
Open:
$2.37
24h Volume:
494.47K
Relative Volume:
0.28
Market Cap:
$289.65M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.3997
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
+1.02%
1M Performance:
+21.32%
6M Performance:
-51.75%
1Y Performance:
-50.99%
1-Day Range:
Value
$2.30
$2.50
1-Week Range:
Value
$2.30
$2.53
52-Week Range:
Value
$1.285
$7.85

Annexon Inc Stock (ANNX) Company Profile

Name
Name
Annexon Inc
Name
Phone
(650)-822-5500
Name
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Name
Employee
100
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
ANNX's Discussions on Twitter

Compare ANNX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ANNX
Annexon Inc
2.48 289.65M 0 -134.24M -121.34M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.17 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
538.05 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.70 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
550.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.06 28.51B 3.81B -644.79M -669.77M -6.24

Annexon Inc Stock (ANNX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-01-24 Upgrade JP Morgan Neutral → Overweight
Dec-21-23 Upgrade BofA Securities Neutral → Buy
Oct-30-23 Initiated Wells Fargo Overweight
May-26-23 Downgrade BofA Securities Buy → Neutral
May-25-23 Downgrade JP Morgan Overweight → Neutral
Sep-16-22 Initiated Jefferies Buy
Sep-09-22 Initiated BTIG Research Buy
Nov-30-21 Initiated H.C. Wainwright Buy
Sep-23-21 Initiated Cantor Fitzgerald Overweight
Jan-26-21 Initiated Needham Buy
Aug-18-20 Initiated BofA Securities Buy
Aug-18-20 Initiated Cowen Outperform
Aug-18-20 Initiated JP Morgan Overweight
View All

Annexon Inc Stock (ANNX) Latest News

pulisher
Jun 18, 2025

Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025 - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrop - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Sells 137,220 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 17, 2025
pulisher
Jun 17, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Sold by Park Avenue Securities LLC - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Market Highlights: Annexon Inc (ANNX) Ends on a Low Note at 2.49 - DWinneX

Jun 16, 2025
pulisher
Jun 13, 2025

Annexon Inc (ANNX) Stock: A Comprehensive 52-Week Review - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

49,062 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Bought by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Estimates Annexon FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

Annexon Biosciences Holds Annual Stockholders Meeting - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Reduces Stock Holdings in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 49,438 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Transcript : Annexon, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com

Jun 05, 2025
pulisher
Jun 03, 2025

Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight - GlobeNewswire Inc.

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Makes New $59,000 Investment in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Buys 14,475 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Bought by Jane Street Group LLC - Defense World

May 30, 2025
pulisher
May 29, 2025

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference | ANNX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 26, 2025

Nuveen Asset Management LLC Acquires 164,915 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 26, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Invests $177,000 in Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 26, 2025
pulisher
May 25, 2025

Annexon, Inc. (NASDAQ:ANNX) Stock Holdings Raised by Ameriprise Financial Inc. - Defense World

May 25, 2025
pulisher
May 22, 2025

Deutsche Bank AG Acquires 28,448 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 22, 2025
pulisher
May 21, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by Northern Trust Corp - Defense World

May 21, 2025
pulisher
May 20, 2025

Annexon reports promising Guillain-Barré treatment results By Investing.com - Investing.com India

May 20, 2025
pulisher
May 19, 2025

Annexon (ANNX) Highlights Promising Results from Tanruprubart Ph - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Annexon reports promising Guillain-Barré treatment results - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Annexon Showcases Tanruprubart Data Demonstrating Improved Clini - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Annexon Showcases Tanruprubart Data Demonstrating Improved - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting - The Manila Times

May 19, 2025
pulisher
May 19, 2025

New GBS Drug Shows 3X Better Outcomes Than Standard Care in Clinical Trial | ANNX Stock News - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Annexon Inc (NASDAQ: ANNX) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

May 19, 2025
pulisher
May 17, 2025

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 17, 2025
pulisher
May 16, 2025

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) | ANNX Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Annexon Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Annexon Awards $387K Worth of Stock Options to New Hires: Inside the Compensation Package - Stock Titan

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Issues Negative Estimate for Annexon Earnings - Defense World

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Has Lowered Expectations for Annexon (NASDAQ:ANNX) Stock Price - Defense World

May 16, 2025
pulisher
May 15, 2025

Needham & Company LLC Has Lowered Expectations for Annexon (NASDAQ:ANNX) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga

May 14, 2025
pulisher
May 14, 2025

Annexon (ANNX) Receives Revised Price Target from HC Wainwright - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Schonfeld Strategic Advisors LLC Sells 589,091 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 14, 2025
pulisher
May 13, 2025

Cantor Fitzgerald maintains Overweight on Annexon stock By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Annexon (ANNX) Sees Price Target Cut to $14 by H.C. Wainwright | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Annexon Inc Reports Q1 2025 EPS of -$0.37, Missing Estimates; Re - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Annexon (ANNX) Maintains "Buy" Rating Despite Price Target Cut | ANNX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Annexon Biosciences Reports Increased Q1 2025 Losses - TipRanks

May 13, 2025
pulisher
May 12, 2025

Annexon, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Annexon Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

Annexon Inc Stock (ANNX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Annexon Inc Stock (ANNX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Feb 18 '25
Sale
2.97
5,515
16,380
83,814
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Feb 18 '25
Sale
2.91
8,345
24,284
61,237
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Feb 18 '25
Sale
2.95
6,618
19,523
86,579
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Feb 18 '25
Sale
2.92
6,912
20,183
77,770
Love Douglas
PRESIDENT AND CEO
Feb 13 '25
Sale
2.95
5,021
14,812
351,554
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Feb 13 '25
Sale
2.98
1,786
5,322
84,682
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Feb 13 '25
Sale
2.99
1,425
4,261
93,197
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Feb 13 '25
Sale
2.99
1,783
5,331
69,582
$20.82
price up icon 0.75%
$35.69
price down icon 0.97%
$21.41
price up icon 0.75%
$98.07
price down icon 2.44%
$108.21
price up icon 1.71%
biotechnology ONC
$244.98
price up icon 1.18%
Cap:     |  Volume (24h):